Eddy Pharmaceuticals announced that Fu Heliang, one of the company's actual controllers and chairman, previously disclosed plans to increase his holdings and plans to increase his holdings of the company within 6 months from March 2, 2026, with an increase of no less than 10 million yuan and no more than 15 million yuan. From March 4, 2026 to July 31, 2026, Fu Heliang increased his holdings of the company's shares by 7301,000 shares through centralized bidding, accounting for 0.17% of the company's total share capital. The total increase amount was RMB 11.3047 million, which has already exceeded the lower limit of the amount of the plan to increase his holdings. The implementation of this plan to increase his holdings has been completed.

Eddy Pharmaceuticals announced that Fu Heliang, one of the company's actual controllers and chairman, previously disclosed plans to increase his holdings and plans to increase his holdings of the company within 6 months from March 2, 2026, with an increase of no less than 10 million yuan and no more than 15 million yuan. From March 4, 2026 to July 31, 2026, Fu Heliang increased his holdings of the company's shares by 7301,000 shares through centralized bidding, accounting for 0.17% of the company's total share capital. The total increase amount was RMB 11.3047 million, which has already exceeded the lower limit of the amount of the plan to increase his holdings. The implementation of this plan to increase his holdings has been completed.